![]() |
市场调查报告书
商品编码
1345423
全球医学影像市场 - 2023-2030Global Medical Imaging Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
概述
全球医学影像市场在 2022 年达到 402 亿美元,预计到 2030 年将达到 593 亿美元,2023-2030 年预测期间复合年增长率为 5.1%。
医学成像涉及对身体内部进行成像以进行临床分析和医疗干预的过程,以及某些器官或组织功能的视觉表示。每种类型的成像技术都会提供有关正在研究或治疗的身体区域的不同信息,这些信息与可能的疾病、损伤或医疗治疗的有效性相关。
医学成像技术带来了临床解剖学和法医病理学的巨大进步。新兴技术使医疗保健专业人员能够从不同的角度观察和理解人体。常用的医学成像设备包括X射线、计算机断层扫描(CT)、正电子发射断层扫描(PET)、超声波和磁共振成像(MRI)。
此外,政府和私人组织投资增加、产品发布以及研发不断增加等重要增长动力将推动未来市场的增长。 Koninklijke Philips NV、GE Healthcare、Shimadzu Corporation、Toshiba Medical Systems Inc. 等重要参与者都在市场上积极运营。
动力学
增加医疗成像设备的产品推出预计将推动市场增长
医学成像设备广泛用于诊断肌肉骨骼疾病、心脏病、癌症和慢性肺部疾病等慢性疾病。大公司的重大技术进步有助于推动市场增长。这些有效的产品发布有助于将研究发现转化为新的治疗方法,并改善对数百万慢性病患者的护理。
例如,2023 年 7 月,柯尼卡美能达医疗保健美洲公司推出了 PocketPro H2,这是一款新型无线手持式超声设备,用于护理点应用中的一般成像。 PocketPro H2 线性无线手持式超声系统针对肌肉骨骼 (MSK)、疼痛管理、血管通路和针引导应用进行了优化。具有出色的图像质量。
此外,飞利浦于 2023 年 5 月推出了飞利浦图像引导治疗移动 C 形臂系统 1000,名为 Zenition 10。飞利浦 Zenition 10 旨在通过提供速度和效率来解决高患者吞吐量问题。它还可以灵活地满足创伤、骨科和其他手术领域的要求。因此,上述因素有助于提振市场。
政府和私人组织的投资刺激了其在全球市场的需求
政府在全球医疗设备的采购、定价和分销方面发挥着重要作用。各国政府采取各种倡议来发展医疗保健基础设施,以便为公众提供安全且具有成本效益的医疗产品。政府机构的资助也有助于开设新设施。此外,实施符合进出口的法规预计将有助于为市场创造收入。
例如,2023 年 5 月,英国政府拨款 23 亿英镑建设 160 个新的社区诊断中心,以减轻 NHS 的压力并改善患者护理。预计每年可提供超过 500,000 次额外检查、成像和扫描。
此外,2023 年 3 月,加拿大全球医疗技术创新公司 Synaptive Medical Inc. 获得加拿大出口发展局 (EDC) 4000 万美元的投资,用于加速手术、成像和数据技术的发展。这笔 4000 万美元的投资用于开发和扩大对加拿大製造的手术机器人、MRI 以及医学成像和手术室数据平台的使用。
医疗成像设备的产品召回将阻碍全球医疗成像设备市场的增长
过去几年,全球医学成像市场发生了重大产品召回事件。当产品缺陷可能影响或伤害消费者、损害公司声誉并阻碍市场增长时,就会发生产品召回。越来越多的此类事件导致不准确的错误,并且在医学成像市场上出现了一些重大的产品召回事件。
例如,2022 年 5 月 26 日,雅培医疗在美国召回了 4,800 个 Dragonfly OpStar 成像导管。此外,2023 年 2 月,GE HealthCare 召回了一些可能导致严重伤害或死亡的核医学成像系统。它属于 GE 的核医学 600 和 800 系列系统,用于检测和诊断癌症和神经系统疾病。
Global Medical Imaging Market reached US$ 40.2 billion in 2022 and is expected to reach US$ 59.3 billion by 2030 growing with a CAGR of 5.1% during the forecast period 2023-2030.
Medical imaging involves the process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. Each type of imaging technology gives different information about the area of the body being studied or treated which is related to possible disease, injury, or the effectiveness of medical treatment.
Medical imaging techniques have led to great advances in clinical anatomy and forensic pathology. New and emerging technologies allow healthcare professionals to view and understand the human body from different perspectives. Commonly used medical imaging equipment includes X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound, and magnetic resonance imaging (MRI).
Furthermore, significant growth drivers such as the increasing investments by government and private organizations, product launches, and rising research and developments give rise to future market growth. Significant key players like Koninklijke Philips N.V., GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., and others are actively operating in the market.
Medical imaging devices are widely used in diagnosing chronic conditions like musculoskeletal disorders, cardiac disease, cancers, and chronic lung diseases. The major technological advancements by major companies help to drive market growth. These effective product launches help to transform research discoveries into new treatments and improve care for millions of people with chronic diseases.
For instance, in July 2023, Konica Minolta Healthcare Americas, Inc., launched PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications. The PocketPro H2 linear wireless handheld ultrasound system is optimized for musculoskeletal (MSK), pain management, vascular access, and needle guidance applications. with excellent image quality.
Additionally, in May 2023, Philips launched the Philips Image Guided Therapy Mobile C-arm System 1000, named Zenition 10. Philips Zenition 10 is designed to address high patient throughput by providing speed and efficiency. It also provides the flexibility to accommodate the requirements of trauma, orthopedics, and other areas of surgery. Thus, the above factors help to boost the market.
Government plays an important role in purchasing, pricing, and distributing medical devices globally. Governments undertake various initiatives to develop healthcare infrastructure to provide safe and cost-effective medical products to the public. The funding by government bodies also helps in opening new facilities. Also, implementing regulations that comply with imports and exports is expected to help generate revenue for the market.
For instance, in May 2023, the United Kingdom Government funded £2.3 billion into 160 new community diagnostic centers to reduce pressure on the NHS and improve patient care. It is expected to provide over 500,000 additional checkups, imaging, and scans a year.
Additionally, in March 2023, Synaptive Medical Inc., a global medical technology innovator in Canada, secured a USD $40 million investment from Export Development Canada (EDC) to accelerate surgical, imaging, and data technologies. The $40 million investment is to develop and expand access to Canadian-made surgical robotics, MRI, and data platforms for medical imaging and operating rooms.
The global medical imaging market has witnessed major product recalls in the past few years. Product recalls occur when a product defect could affect or harm the consumer, hampers a company's reputation, and hinders market growth. An increasing number of such instances result in inaccuracy errors and some major instances of product recall witnessed in the medical imaging market.
For instance, on 26 May 2022, Abbott Medical Recalled 4,800 Dragonfly OpStar Imaging Catheters in the U.S. Additionally, in February 2023, GE HealthCare recalled some of its nuclear medicine imaging systems that could cause serious injury or death. It pertains to GE's Nuclear Medicine 600 and 800 Series systems, used for detecting and diagnosing cancer, and neurological disorders.
The global medical imaging market is segmented based on product, application, end users, and region.
The X-ray segment has the most significant share of the medical imaging equipment market due to the system's versatility and convenience. An X-ray is a noninvasive medical imaging test that helps physicians diagnose and treat medical conditions. X-rays diagnose skeletal systems, oral cavities, lungs, breast, digestive systems, and ingested objects. The growth in the X-ray segment is mainly due to its cost-effectiveness
For instance, in July 2022, Shimadzu Corporation introduced a New Type of Mobile X-ray System Outside of Japan, accommodating a Wide Range of Needs for Mobile X-ray Systems. This system incorporates digital radiography (DR) and this Mobile X-ray system provides diagnostic imaging and can travel to patient rooms, operating rooms, and emergency areas.
For instance, on August 02, 2022, GE Healthcare launched its most advanced fixed X-ray system called the next-generation Definium 656 HD. The Definium 656 HD, featuring the Intelligent Workflow Suite, is a versatile and digital radiographic system powered by GE's FlashPad HD high-resolution detectors and the latest Helix 2.2 advanced image processing software.
North America has maintained a significant proportion of the medical imaging market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as rising product launches, healthcare expenditure, and research and developments in medical imaging equipment.
For instance, in August 2023, GE HealthCare launched the handheld ultrasound device Vscan Air SL. The dual-headed probe of Vscan Air SL enables clinicians to access sector and linear arrays on the same device that is capable of facilitating rapid vascular and cardiac assessments of patients.
The major global players in the market include: Koninklijke Philips N.V, GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., Ziehm Imaging Inc., Varian Medical Sytems, Aribex Corporation, Fujifilm Holdings Corporation, Siemens Healthcare, Hitachi Ltd. among others.
The COVID-19 pandemic has had a significant impact on the medical imaging market. During the height of the pandemic, many healthcare systems were overwhelmed, and non-urgent medical procedures and screenings were postponed or canceled. This led to delays in medical imaging device research and product launches. Clinical trials are vital for developing new treatments and improving outcomes in the medical imaging market.
However, the pandemic disrupted the conduct of clinical trials, with many sites temporarily halting enrollment or modifying protocols to prioritize patient safety. This has led to delays in the completion of trials and the availability of new therapies. Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical imaging market is expected to be moderately affected over the forecast period.
The global medical imaging market report would provide approximately 69 tables, 70 figures, and 195 Pages.
LIST NOT EXHAUSTIVE